Data / Drug companies / Olopatadine hydrochloride
Olopatadine hydrochloride: 35 companies and 71 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Olopatadine hydrochloride is listed in the FDA National Drug Code Directory by 35 companies, with 71 products in commercial distribution. 68 of the products (95.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; solution/ drops; spray, and the newest product started marketing on November 1, 2026.
The request: Get every company that lists olopatadine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 35
- Products
- 71
- Generic (ANDA) products
- 68 (95.8%)
- Application numbers
- 21
- Routes
- Ophthalmic, Nasal
- Brand names
- Eye Allergy Itch Relief, Pataday Once Daily Relief, Pataday Twice a Day Relief, Olopatadine HCl, Retaine Allergy, Eye Allergy Itch and Redness Relief
- openFDA record search
- api.fda.gov
Companies that list olopatadine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aurohealth LLC | 6 | solution | Generic drugs (ANDA) | July 15, 2020 |
| Alembic Pharmaceuticals Inc. | 4 | solution/ drops | Generic drugs (ANDA) | February 18, 2021 |
| Walmart Inc. | 4 | solution; solution/ drops | Generic drugs (ANDA) | November 1, 2026 |
| Alcon Laboratories, Inc. | 3 | solution | New drug applications (NDA) | September 1, 2020 |
| Amerisource Bergen | 3 | solution | Generic drugs (ANDA) | May 1, 2026 |
| Apotex Corp. | 3 | solution/ drops; spray, metered | Generic drugs (ANDA) | October 6, 2022 |
| Cardinal Health 110, LLC. DBA Leader | 3 | solution/ drops; solution | Generic drugs (ANDA) | January 15, 2026 |
| Walgreen Company | 3 | solution | Generic drugs (ANDA) | December 22, 2025 |
| Yyba Corp | 3 | solution | Generic drugs (ANDA) | September 10, 2026 |
| A-S Medication Solutions | 2 | solution | Generic drugs (ANDA) | July 15, 2020 |
| Alembic Pharmaceuticals Limited | 2 | solution/ drops | Generic drugs (ANDA) | February 18, 2021 |
| Bausch & Lomb Incorporated | 2 | solution | Generic drugs (ANDA) | January 20, 2025 |
| BluePoint Laboratories | 2 | solution | Generic drugs (ANDA) | December 5, 2025 |
| Harris Teeter | 2 | solution | Generic drugs (ANDA) | July 15, 2020 |
| Kroger Company | 2 | solution | Generic drugs (ANDA) | July 15, 2020 |
| Meijer, Inc. | 2 | solution | Generic drugs (ANDA) | July 15, 2020 |
| Retail Business Services, LLC | 2 | solution | Generic drugs (ANDA) | May 6, 2021 |
| Rising Pharma Holdings, Inc. | 2 | solution | Generic drugs (ANDA) | May 1, 2025 |
| Rite Aid Corporation | 2 | solution | Generic drugs (ANDA) | July 15, 2020 |
| Rugby Laboratories | 2 | solution/ drops | Generic drugs (ANDA) | January 15, 2026 |
| Target Corporation | 2 | solution; solution/ drops | Generic drugs (ANDA) | August 15, 2026 |
| Topco Associates LLC | 2 | solution | Generic drugs (ANDA) | July 15, 2020 |
| Allegiant Health | 1 | solution/ drops | Generic drugs (ANDA) | May 5, 2025 |
| Allwell Health Inc | 1 | solution | Generic drugs (ANDA) | July 15, 2020 |
| Amneal Pharmaceuticals LLC | 1 | spray, metered | Generic drugs (ANDA) | February 3, 2020 |
| Bryant Ranch Prepack | 1 | spray | Generic drugs (ANDA) | June 14, 2017 |
| Bryant Ranch Prepack | 1 | spray | Generic drugs (ANDA) | June 14, 2017 |
| Dr. Reddy's Laboratories Inc. | 1 | solution/ drops | Generic drugs (ANDA) | April 15, 2026 |
| Glenmark Therapeutics Inc., USA | 1 | solution | Generic drugs (ANDA) | February 28, 2025 |
| Golden State Medical Supply, Inc. | 1 | solution/ drops | Generic drugs (ANDA) | December 7, 2015 |
| OCuSOFT LLC | 1 | solution/ drops | Generic drugs (ANDA) | July 5, 2024 |
| Padagis Israel Pharmaceuticals Ltd | 1 | spray | Generic drugs (ANDA) | June 14, 2017 |
| Somerset Therapeutics, LLC | 1 | solution/ drops | Generic drugs (ANDA) | December 20, 2024 |
| Sportpharm LLC | 1 | solution | Generic drugs (ANDA) | July 15, 2020 |
| Valu Merchandisers Company | 1 | solution | Generic drugs (ANDA) | July 15, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 47 | 66.2% |
| Solution/ drops | 19 | 26.8% |
| Spray | 3 | 4.2% |
| Spray, metered | 2 | 2.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 68 | 95.8% |
| New drug applications (NDA) | 3 | 4.2% |
Pharmacologic classes
| Class | Products |
|---|---|
| Histamine-1 Receptor Inhibitor | 71 |
| Histamine-1 Receptor Antagonist | 55 |
| Mast Cell Stabilizer | 55 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.